LPA and congenital bilateral aplasia of vas deferens from CFTR mutation: Testing for Lp(a) should also be considered in patients with suboptimal reduction in LDL-C despite good adherence to statin therapy, as well as in those with a history of progressive CAVD (Cegla et al., 2019; Wilson et al., 2019; Handelsman et al., 2020).